Clinical Trial Update: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease [Phase 2, Phase 3]

View source ↗

Summary

NRG Oncology reports a Phase 2/Phase 3 trial evaluating adjuvant chemotherapy guided by residual disease in Stage III colon cancer; the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: NRG Oncology | Conditions: Stage III Colon Cancer | Phase 2, Phase 3 | Status: RECRUITING